Top

Published in:

01-01-2004 | Review Article

The Role of Exercise in the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes Mellitus

Authors: Jonathan M. McGavock, Neil D. Eves, Sandra Mandic, Nicole M. Glenn, H. Arthur Quinney, Mark J. Haykowsky

Published in: Sports Medicine | Issue 1/2004

Abstract

The role of exercise training in the prevention and treatment of type 2 diabetes mellitus has been studied extensively over the past two decades. Although the primary treatment aim for patients with type 2 diabetes is metabolic control, the morbidity and mortality associated with the disease is more a function of cardiovascular disease. As exercise is associated with favourable reductions in the risk for cardiovascular disease in other high-risk populations, here we explore the role of exercise in the treatment of cardiovascular maladaptations associated with type 2 diabetes.

The cardiovascular adaptation to type 2 diabetes is characterised by hypertrophy, stiffening and loss of functional reserve. Clinically, the cardiovascular adaptations to the diabetic state are associated with an increased risk for cardiovascular disease. Functionally, these adaptations have been shown to contribute to a reduced exercise capacity, which may explain the reduced cardiovascular fitness observed in this population.

Exercise training is associated with improved exercise capacity in various populations, including type 2 diabetes. Several structural and functional adaptations within the cardiovascular system following exercise training could explain these findings, such as reductions in ventricular and vascular structural hypertrophy and compliance coupled with increased functional reserve. Although these cardiovascular adaptations to aerobic exercise training have been well documented in older populations with similar decrements in cardiovascular fitness and function, they have yet to be examined in patients with type 2 diabetes. For this reason, we contend that exercise training may be an excellent therapeutic adjunct in the treatment of diabetic cardiovascular disease.

Celsus AC. De medicina (Spencer WG, trans) [Book IV 27.1]. Cambridge: Harvard University Press, 1935; I: E–28.2

Joslin EP, Root HF, White P, et al. The treatment of diabetes mellitus. Philadelphia (PA): Lea Febiger, 1935

Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–50PubMed

American College of Sports Medicine and American Diabetes Association joint position statement. Diabetes mellitus and exercise. Med Sci Sports Exerc 1997; 29: i–vi

Haffner SM, Lehto S, Ronnemma T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without myocardial infarction. N Engl J Med 1998; 339: 229–34PubMed

Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979; 241: 2035–8PubMed

Devereux RB, Roman MJ, Paranicas M, et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 2000; 101: 2271–6PubMed

McVeigh G, Brennan G, Hayes R, et al. Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis. Am J Med 1993; 95: 424–30PubMed

Fletcher GF, Balady G, Blair SN, et al. Statement on exercise: benefits and recommendations for physical activity programs for all Americans: a statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation 1996; 94: 857–62PubMed

10.

Factor SM, Minase T, Sonnenblick EM. Clinical and morphologic features of human hypertensive diabetic cardiomyopathy. Am Heart J 1980; 99: 446–58PubMed

11.

Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Prog Cardiovasc Dis 1985; 27: 255–70PubMed

12.

Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: part I: general concepts. Circulation 2002; 105: 1727–33PubMed

13.

Galderisi M, Anderson KM, Wilson PWF, et al. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy: the Framingham Heart Study. Am J Cardiol 1991; 68: 85–9PubMed

14.

Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham Study. Am J Cardiol 1974; 34: 29–34PubMed

15.

Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–6PubMed

16.

Barrett-Connor EL, Cohn BA, Wingard DL, et al. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men?: the Rancho Bernardo Study. JAMA 1991; 265: 627–31PubMed

17.

de Simone G, Devereux RB, Roman MJ, et al. Assessment of left ventricular function by the mid-wall fractional shortening-end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23: 1444–51PubMed

18.

Fang ZY, Yuda S, Anderson V, et al. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol 2003; 41: 611–7PubMed

19.

Hsu KL, Chiang FT, Lo HM, et al. Cardiac contractility in noninsulin dependent diabetes mellitus evaluated using the relation between endsystolic wall stress and velocity of circumferential fiber shortening. Jpn Heart J 1997; 38: 463–71PubMed

20.

Sasso FC, Carbonara O, Cozzolino D, et al. Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients: a radionuclide ventriculographic study. J Am Coll Cardiol 2000; 36: 219–26PubMed

21.

Takahashi N, Iwasaka T, Sugiura T, et al. Left ventricular dysfunction during dynamic exercise in noninsulin-dependent diabetic patients with retinopathy. Cardiology 1991; 78: 23–30PubMed

22.

Poirier P, Bogaty P, Garneau C, et al. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001; 24: 5–10PubMed

23.

Poirier P, Garneau C, Bogaty P, et al. Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well-controlled type 2 diabetes mellitus. Am J Cardiol 2000; 85: 473–7PubMed

24.

Liu JE, Palmieri V, Roman MJ, et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 2001; 37: 1943–9PubMed

25.

Zabalgoitia M, Ismaeil MF, Anderson L, et al. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol 2001; 87: 320–3PubMed

26.

Bella JN, Palmieri V, Roman MJ, et al. Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation 2002; 105: 1928–33PubMed

27.

Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 2003; 21: 3–12PubMed

28.

Alpert MA, Lambert CR, Terry BE, et al. Influence of left ventricular mass on left ventricular diastolic filling in normotensive morbid obesity. Am Heart J 1995; 130: 1068–73PubMed

29.

Alpert MA, Terry BE, Mulekar M, et al. Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol 1997; 80: 736–40PubMed

30.

Mureddu GF, de Simone G, Greco R, et al. Left ventricular filling pattern in uncomplicated obesity. Am J Cardiol 1996; 77: 509–14PubMed

31.

Nagano N, Nagano M, Yo Y, et al. Role of glucose intolerance in cardiac diastolic function in essential hypertension. Hypertension 1994; 23: 1002–5PubMed

32.

Seto S, Kapuku GK, Kawahara F, et al. Influence of mild to moderate obesity on left ventricular stress filling pattern in hypertension. Hypertens Res 1998; 21: 245–50PubMed

33.

Vanoverschelde JJ, Essamri B, Vanbutsele R, et al. Contribution of left ventricular diastolic function to exercise capacity in normal subjects. J Appl Physiol 1993; 74: 2225–33PubMed

34.

Lapu-Bula R, Robert A, De Kock M, et al. Relation of exercise capacity to left ventricular systolic function and diastolic filling in idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 1999; 83: 728–34PubMed

35.

Sakate Y, Yoshiyama M, Hirata K, et al. Relationship between Doppler-derived left ventricular diastolic function and exercise capacity in patients with myocardial infarction. Jpn Circ J 2001; 65: 627–31PubMed

36.

Kitzman DW, Higginbotham MB, Cobb FR, et al. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991; 17: 1065–72PubMed

37.

Danielsen R, Nordrehaug JE, Vik-Mo H. Left ventricular performance during exercise in long-term type 1 diabetic men: an echocardiographic study. Clin Physiol 1988; 8: 475–86PubMed

38.

Borow KM, Jaspan JB, Williams KA, et al. Myocardial mechanics in young adult patients with diabetes mellitus: effects of altered load, inotropic state and dynamic exercise. J Am Coll Cardiol 1990; 15: 1508–17PubMed

39.

Arbab-Zadeh A, Dijk E, Palmer D, et al. Prolonged endurance training preserves cardiac compliance with aging [abstract]. Med Sci Sports Exerc 2003; 35: S154

40.

Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115–26PubMed

41.

Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol 1994; 140: 669–82PubMed

42.

Hodes RJ, Lakatta EG, McNeil CT. Another modifiable risk factor for cardiovascular disease?: some evidence points to arterial stiffness. J Am Geriatr Soc 1995; 43: 581–2PubMed

43.

Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899–906PubMed

44.

O’Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14–22PubMed

45.

O’Leary DH, Polak JF, Kronmal RA, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke 1992; 23: 1752–60PubMed

46.

Nagai Y, Metter EJ, Earley CJ, et al. Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. Circulation 1998; 98: 1504–9PubMed

47.

Kawamori R, Yamasaki Y, Matsushima H, et al. Prevalence of carotid atherosclerosis in diabetic patients: ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care 1992; 15: 1290–4PubMed

48.

Pujia A, Gnasso A, Irace C, et al. Common carotid arterial wall thickness in NIDDM subjects. Diabetes Care 1994; 17: 1330–6PubMed

49.

Niskanen L, Rauramaa R, Miettinen H, et al. Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects. Stroke 1996; 27: 1986–92PubMed

50.

Wagenknecht LE, Mayer EJ, Rewers M, et al. The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. Ann Epidemiol 1995; 5: 464–72PubMed

51.

Howard G, O’Leary DH, Zaccaro D, et al. Insulin sensitivity and atherosclerosis: the Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996; 93: 1809–17PubMed

52.

Wagenknecht LE, D’Agostino Jr R, Savage PJ, et al. Duration of diabetes and carotid wall thickness: the Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1997; 28: 999–1005PubMed

53.

Wagenknecht LE, D’Agostino Jr RB, Haffner SM, et al. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Diabetes Care 1998; 21: 1812–8PubMed

54.

Lange LA, Bowden DW, Langefeld CD, et al. Heritability of carotid artery intima-medial thickness in type 2 diabetes. Stroke 2002; 33: 1876–81PubMed

55.

Kinlay S, Creager MA, Fukumoto M, et al. Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension 2001; 38: 1049–53PubMed

56.

O’Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 1990; 15: 339–47PubMed

57.

Cameron JD, Gatzka CD, Kingwell BA. Assessment of large artery function. Coron Artery Dis 2002; 13: 405–13PubMed

58.

Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a ‘set up’ for vascular disease. Circulation 2003; 107: 139–46PubMed

59.

Taniwaki H, Kawagishi T, Emoto M, et al. Correlation between the intima-media thickness of the carotid artery and aorticpulse-wave velocity in patients with type 2 diabetes: vessel wall properties in type 2 diabetes. Diabetes Care 1999; 22: 1851–7PubMed

60.

O’Neal DN, Dragicevic G, Rowley KG, et al. A cross-sectional study of the effects of type 2 diabetes and other cardiovascular risk factors on structure and function of nonstenotic arteries of the lower limb. Diabetes Care 2003; 26: 199–205PubMed

61.

Cohn JN. Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision making. Am J Hypertens 2001; 14: 258S–63SPubMed

62.

Romney JS, Lewanczuk RZ. Vascular compliance is reduced in the early stages of type 1 diabetes. Diabetes Care 2001; 24: 2102–6PubMed

63.

Lehmann ED, Gosling RG, Sonksen PH. Arterial wall compliance in diabetes. Diabet Med 1992; 9: 114–9PubMed

64.

Salomaa V, Riley W, Kark JD, et al. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes: The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 1995; 91: 1432–43PubMed

65.

Simons PC, Algra A, Bots ML, et al. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients: the SMART Study. Second Manifestations of ARTerial disease. Circulation 1999; 100: 951–7PubMed

66.

Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002–12PubMed

67.

Gewaltig MT, Kojda G. Vasoprotection by nitric oxide: mechanisms and therapeutic potential. Cardiovasc Res 2002; 55: 250–60PubMed

68.

Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–5PubMed

69.

Celermajer DS. Endothelial dysfunction: does it matter?: is it reversible? J Am Coll Cardiol 1997; 30: 325–33PubMed

70.

Watts GF, O’Brien SF, Silvester W, et al. Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. Clin Sci (Lond) 1996; 91: 567–73

71.

Williams SB, Cusco JA, Roddy MA, et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1996; 27: 567–74PubMed

72.

Hogikyan RV, Galecki AT, Pitt B, et al. Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes independent of obesity. J Clin Endocrinol Metab 1998; 83: 1946–52PubMed

73.

Steinberg HO, Chaker H, Learning R, et al. Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest 1996; 97: 2601–10PubMed

74.

Balletshofer BM, Rittig K, Enderle MD, et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 2000; 101: 1780–4PubMed

75.

Title LM, Cummings PM, Giddens K, et al. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. J Am Coll Cardiol 2000; 36: 2185–91PubMed

76.

McNeill KL, Fontana L, Russell-Jones DL, et al. Inhibitory effects of low-density lipoproteins from men with type II diabetes on endothelium-dependent relaxation. J Am Coll Cardiol 2000; 35: 1622–7PubMed

77.

Makimattila S, Liu ML, Vakkilainen J, et al. Impaired endothelium-dependent vasodilation in type 2 diabetes: relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care 1999; 22: 973–81PubMed

78.

Shige H, Ishikawa T, Suzukawa M, et al. Endothelium-dependent flow-mediated vasodilation in the postprandial state in type 2 diabetes mellitus. Am J Cardiol 1999; 84: 1272–4, A9PubMed

79.

Preik M, Kelm M, Rosen P, et al. Additive effect of coexistent type 2 diabetes and arterial hypertension on endothelial dysfunction in resistance arteries of human forearm vasculature. Angiology 2000; 51: 545–54PubMed

80.

Mather KJ, Verma S, Anderson TJ. Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol 2001; 37: 1344–50PubMed

81.

Rask-Madsen C, Ihlemann N, Krarup T, et al. Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease. Diabetes 2001; 50: 2611–8PubMed

82.

Gaenzer H, Neumayr G, Marschang P, et al. Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus. Am J Cardiol 2002; 89: 431–4PubMed

83.

Caballero AE, Saouaf R, Lim SC, et al. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial. Metabolism 2003; 52: 173–80PubMed

84.

van de Ree MA, Huisman MV, de Man FH, et al. Impaired endothelium-dependent vasodilation in type 2 diabetes mellitus and the lack of effect of simvastatin. Cardiovasc Res 2001; 52: 299–305PubMed

85.

van Etten RW, de Koning EJ, Honing ML, et al. Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 2002; 22: 799–804PubMed

86.

Bagg W, Whalley GA, Gamble G, et al. Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes. Intern Med J 2001; 31: 322–8PubMed

87.

Mather KJ, Mirzamohammadi B, Lteif A, et al. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes 2002; 51: 3517–23PubMed

88.

Morise T, Takeuchi Y, Kawano M, et al. Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care 1995; 18: 87–9PubMed

89.

Cardillo C, Campia U, Bryant MB, et al. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation 2002; 106: 1783–7PubMed

90.

McAuley DF, McGurk C, Nugent AG, et al. Vasoconstriction to endothelin-1 is blunted in non-insulin-dependent diabetes: a dose-response study. J Cardiovasc Pharmacol 2000; 36: 203–8PubMed

91.

Oliver FJ, de la Rubia G, Feener EP, et al. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem 1991; 266: 23251–6PubMed

92.

Ferri C, Pittoni V, Piccoli A, et al. Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab 1995; 80: 829–35PubMed

93.

Myers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346: 793–801PubMed

94.

Wei M, Gibbons LW, Kampert JB, et al. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med 2000; 132: 605–11PubMed

95.

Wilson TM, Tanaka H. Meta-analysis of the age-associated decline in maximal aerobic capacity in men: relation to training status. Am J Physiol Heart Circ Physiol 2000; 278: H829–34PubMed

96.

Fitzgerald MD, Tanaka H, Tran ZV, et al. Age-related declines in maximal aerobic capacity in regularly exercising vs sedentary women: a meta-analysis. J Appl Physiol 1997; 83: 160–5PubMed

97.

Richardson RS. What governs skeletal muscle \({\dot {\rm V}}{\rm O}_{{2}{\rm max}}\)?: new evidence. Med Sci Sports Exerc 2000; 32: 100–7PubMed

98.

Baldi JC, Aoina JL, Oxenham HC, et al. Reduced exercise arteriovenous O2 difference in type 2 diabetes. J Appl Physiol 2003; 94: 1033–8PubMed

99.

Kingwell BA, Formosa M, Muhlmann M, et al. Type 2 diabetic individuals have impaired leg blood flow responses to exercise: role of endothelium-dependent vasodilation. Diabetes Care 2003; 26: 899–904PubMed

100.

Eriksson KF, Saltin B, Lindgarde F. Increased skeletal muscle capillary density precedes diabetes development in men with impaired glucose tolerance: a 15-year follow-up. Diabetes 1994; 43: 805–8PubMed

101.

Katz MA, McNeill G. Defective vasodilation response to exercise in cutaneous precapillary vessels in diabetic humans. Diabetes 1987; 36: 1386–96PubMed

102.

Katz MA, McCuskey P, Beggs JL, et al. Relationships between microvascular function and capillary structure in diabetic and nondiabetic human skin. Diabetes 1989; 38: 1245–50PubMed

103.

Menon RK, Grace AA, Burgoyne W, et al. Muscle blood flow in diabetes mellitus: evidence of abnormality after exercise. Diabetes Care 1992; 15: 693–5PubMed

104.

Kelley DE, He J, Menshikova EV, et al. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002; 51: 2944–50PubMed

105.

Vodra K, Rath R, Bass A, et al. Enzyme activities in quadriceps femoris muscle of obese diabetic male patients. Diabetologia 1977; 13: 527–9

106.

Lithell H, Lindgarde F, Hellsing K, et al. Body weight, skeletal muscle morphology, and enzyme activities in relation to fasting serum insulin concentrations and glucose tolerance in 48-year-old men. Diabetes 1977; 30: 19–25

107.

Clark Jr CM, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995; 332: 1210–7PubMed

108.

Goodyear LJ, Kahn BB. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 1998; 49: 235–61PubMed

109.

Ivy JL, Zderic TW, Fogt DL. Prevention and treatment of non-insulin-dependent diabetes mellitus. Exerc Sport Sci Rev 1999; 27: 1–35PubMed

110.

Ruderman NB, Schneider SH. Diabetes, exercise, and atherosclerosis. Diabetes Care 1992; 15: 1787–93PubMed

111.

Ruderman NB, Ganda OP, Johansen K. The effect of physical training on glucose tolerance and plasma lipids in maturity-onset diabetes. Diabetes 1979; 28 Suppl. 1: 89–92PubMed

112.

Bogardus C, Ravussin E, Robbins DC, et al. Effects of physical training and diet therapy on carbohydrate metabolism in patients with glucose intolerance and non-insulin-dependent diabetes mellitus. Diabetes 1984; 33: 311–8PubMed

113.

Schneider SH, Amorosa LF, Khachadurian AK, et al. Studies on the mechanism of improved glucose control during regular exercise in type 2 (non-insulin-dependent) diabetes. Diabetologia 1984; 26: 355–60PubMed

114.

Trovati M, Carta Q, Cavalot F, et al. Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients. Diabetes Care 1984; 7: 416–20PubMed

115.

Reitman JS, Vasquez B, Klimes I, et al. Improvement of glucose homeostasis after exercise training in non-insulin-dependent diabetes. Diabetes Care 1984; 7: 434–41PubMed

116.

Ronnemaa T, Mattila K, Lehtonen A, et al. A controlled randomized study on the effect of long-term physical exercise on the metabolic control in type 2 diabetic patients. Acta Med Scand 1986; 220: 219–24PubMed

117.

Lampman RM, Schteingart DE, Santinga JT, et al. The influence of physical training on glucose tolerance, insulin sensitivity, and lipid and lipoprotein concentrations in middle-aged hypertriglyceridaemic, carbohydrate intolerant men. Diabetologia 1987; 30: 380–5PubMed

118.

Skarfors ET, Wegener TA, Lithell H, et al. Physical training as treatment for type 2 (non-insulin-dependent) diabetes in elderly men: a feasibility study over 2 years. Diabetologia 1987; 30: 930–3PubMed

119.

Rogers MA, Yamamoto C, King DS, et al. Improvement in glucose tolerance after 1 wk of exercise in patients with mild NIDDM. Diabetes Care 1988; 11: 613–8PubMed

120.

Ronnemaa T, Marniemi J, Puukka P, et al. Effects of long-term physical exercise on serum lipids, lipoproteins and lipid metabolizing enzymes in type 2 (non-insulin-dependent) diabetic patients. Diabetes Res 1988; 7: 79–84PubMed

121.

Segal KR, Edano A, Abalos A, et al. Effect of exercise training on insulin sensitivity and glucose metabolism in lean, obese, and diabetic men. J Appl Physiol 1991; 71: 2402–11PubMed

122.

Schneider SH, Khachadurian AK, Amorosa LF, et al. Ten-year experience with an exercise-based outpatient life-style modification program in the treatment of diabetes mellitus. Diabetes Care 1992; 15: 1800–10PubMed

123.

Dela F, Ploug T, Handberg A, et al. Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes 1994; 43: 862–5PubMed

124.

Smutok MA, Reece C, Kokkinos PF, et al. Effects of exercise training modality on glucose tolerance in men with abnormal glucose regulation. Int J Sports Med 1994; 15: 283–9PubMed

125.

Lehmann R, Vokac A, Niedermann K, et al. Loss of abdominal fat and improvement of the cardiovascular risk profile by regular moderate exercise training in patients with NIDDM. Diabetologia 1995; 38: 1313–9PubMed

126.

Poirier P, Catellier C, Tremblay A, et al. Role of body fat loss in the exercise-induced improvement of the plasma lipid profile in non-insulin-dependent diabetes mellitus. Metabolism 1996; 45: 1383–7PubMed

127.

Dunstan DW, Mori TA, Puddey IB, et al. The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM: a randomized controlled study. Diabetes Care 1997; 20: 913–21PubMed

128.

Ligtenberg PC, Hoekstra JB, Bol E, et al. Effects of physical training on metabolic control in elderly type 2 diabetes mellitus patients. Clin Sci (Lond) 1997; 93: 127–35

129.

Mourier A, Gautier JF, De Kerviler E, et al. Mobilization of visceral adipose tissue related to the improvement in insulin sensitivity in response to physical training in NIDDM: effects of branched-chain amino acid supplements. Diabetes Care 1997; 20: 385–91PubMed

130.

Eriksson J, Tuominen J, Valle T, et al. Aerobic endurance exercise or circuit-type resistance training for individuals with impaired glucose tolerance? Horm Metab Res 1998; 30: 37–41PubMed

131.

Brandenburg SL, Reusch JE, Bauer TA, et al. Effects of exercise training on oxygen uptake kinetic responses in women with type 2 diabetes. Diabetes Care 1999; 22: 1640–6PubMed

132.

Tessier D, Menard J, Fulop T, et al. Effects of aerobic physical exercise in the elderly with type 2 diabetes mellitus. Arch Gerontol Geriatr 2000; 31: 121–32PubMed

133.

Rigla M, Fontcuberta J, Mateo J, et al. Physical training decreases plasma thrombomodulin in type I and type II diabetic patients. Diabetologia 2001; 44: 693–9PubMed

134.

Gerstenblith G, Frederiksen J, Yin FC, et al. Echocardiographic assessment of a normal adult aging population. Circulation 1977; 56: 273–8PubMed

135.

Pluim BM, Zwinderman AH, van der Laarse A, et al. The athlete’s heart: a meta-analysis of cardiac structure and function. Circulation 2000; 101: 336–44PubMed

136.

Kokkinos PF, Narayan P, Colleran JA, et al. Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med 1995; 333: 1462–7PubMed

137.

Turner MJ, Spina RJ, Kohrt WM, et al. Effect of endurance exercise training on left ventricular size and remodeling in older adults with hypertension. J Gerontol A Biol Sci Med Sci 2000; 55: M245–51PubMed

138.

Baglivo HP, Fabregues G, Burrieza H, et al. Effect of moderate physical training on left ventricular mass in mild hypertensive persons. Hypertension 1990; 15: 1153–6

139.

Wirth A, Kroger H. Improvement of left ventricular morphology and function in obese subjects following a diet and exercise program. Int J Obes Relat Metab Disord 1995; 19: 61–6PubMed

140.

Hinderliter A, Sherwood A, Gullette EC, et al. Reduction of left ventricular hypertrophy after exercise and weight loss in overweight patients with mild hypertension. Arch Intern Med 2002; 162: 1333–9PubMed

141.

Peterson LR, Rinder MR, Schechtman KB, et al. Peak exercise stroke volume: associations with cardiac structure and diastolic function. J Appl Physiol 2003; 94: 1108–14PubMed

142.

Kitzman DW, Sheikh KH, Beere PA, et al. Age-related alterations of Doppler left ventricular filling indexes in normal subjects are independent of left ventricular mass, heart rate, contractility and loading conditions. J Am Coll Cardiol 1991; 18: 1243–50PubMed

143.

Gerdts E, Bjornstad H, Toft S, et al. Impact of diastolic Doppler indices on exercise capacity in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). J Hypertens 2002; 20: 1223–9PubMed

144.

Forman DE, Manning WJ, Hauser R, et al. Enhanced left ventricular diastolic filling associated with long-term endurance training. J Gerontol 1992; 47: M56–8PubMed

145.

Douglas PS, O’Toole M. Aging and physical activity determine cardiac structure and function in the older athlete. J Appl Physiol 1992; 72: 1969–73PubMed

146.

Takemoto KA, Bernstein L, Lopez JF, et al. Abnormalities of diastolic filling of the left ventricle associated with aging are less pronounced in exercise-trained individuals. Am Heart J 1992; 124: 143–8PubMed

147.

Levy WC, Cerqueira MD, Abrass IB, et al. Endurance exercise training augments diastolic filling at rest and during exercise in healthy young and older men. Circulation 1993; 88: 116–26PubMed

148.

Spina RJ, Miller TR, Bogenhagen WH, et al. Gender-related differences in left ventricular filling dynamics in older subjects after endurance exercise training. J Gerontol A Biol Sci Med Sci 1996; 51: B232–7PubMed

149.

Mier CM, Turner MJ, Ehsani AA, et al. Cardiovascular adaptations to 10 days of cycle exercise. J Appl Physiol 1997; 83: 1900–6PubMed

150.

Spina RJ, Turner MJ, Ehsani AA. β-Adrenergic-mediated improvement in left ventricular function by exercise training in older men. Am J Physiol Heart Circ Physiol 1998; 274: H397–404

151.

Spina RJ, Rashid S, Davila-Roman VG, et al. Adaptations in beta-adrenergic cardiovascular responses to training in older women. J Appl Physiol 2000; 89: 2300–5PubMed

152.

Beere PA, Russell SD, Morey MC, et al. Aerobic exercise training can reverse age-related peripheral circulatory changes in healthy older men. Circulation 1999; 100: 1085–94PubMed

153.

Eugene M, Vandewalle H, Bertholon JF, et al. Arterial elasticity and physical working capacity in young men. J Appl Physiol 1986; 61: 1720–3PubMed

154.

Cameron JD, Rajkumar C, Kingwell BA, et al. Higher systemic arterial compliance is associated with greater exercise time and lower blood pressure in a young older population. J Am Geriatr Soc 1999; 47: 653–6PubMed

155.

Rywik TM, Blackman MR, Yataco AR, et al. Enhanced endothelial vasoreactivity in endurance-trained older men. J Appl Physiol 1999; 87: 2136–42PubMed

156.

Rinder MR, Spina RJ, Ehsani AA. Enhanced endothelium-dependent vasodilation in older endurance-trained men. J Appl Physiol 2000; 88: 761–6PubMed

157.

Vaitkevicius PV, Fleg JL, Engel JH, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993; 88: 1456–62PubMed

158.

Tanaka H, DeSouza CA, Seals DR. Absence of age-related increase in central arterial stiffness in physically active women. Arterioscler Thromb Vasc Biol 1998; 18: 127–32PubMed

159.

Tanaka H, Dinenno FA, Monahan KD, et al. Aging, habitual exercise, and dynamic arterial compliance. Circulation 2000; 102: 1270–5PubMed

160.

DeSouza CA, Shapiro LF, Clevenger CM, et al. Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 2000; 102: 1351–7PubMed

161.

Taddei S, Galetta F, Virdis A, et al. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation 2000; 101: 2896–901PubMed

162.

Maiorana A, O’Driscoll G, Cheetham C, et al. The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes. J Am Coll Cardiol 2001; 38: 860–6PubMed

163.

Folsom AR, Eckfeldt JH, Weitzman S, et al. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity: Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke 1994; 25: 66–73PubMed

164.

Olsen MH, Wachteil K, Hermann KL, et al. Maximal exercise capacity is related to cardiovascular structure in patients with longstanding hypertension: a LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. Am J Hypertens 2001; 14: 1205–10PubMed

165.

Tanaka H, Seals DR, Monahan KD, et al. Regular aerobic exercise and the age-related increase in carotid artery intima-media thickness in healthy men. J Appl Physiol 2002; 92: 1458–64PubMed

166.

Moreau KL, Donate AJ, Seals DR, et al. Arterial intima-media thickness: site-specific associations with HRT and habitual exercise. Am J Physiol Heart Circ Physiol 2002; 283: H1409–17PubMed

167.

Schmidt-Trucksass AS, Grathwohl D, et al. Relation of leisure-time physical activity to structural and functional arterial properties of the common carotid artery in male subjects. Atherosclerosis 1999; 145: 107–14PubMed

168.

Dinenno FA, Tanaka H, Monahan KD, et al. Regular endurance exercise induces expansive arterial remodelling in the trained limbs of healthy men. J Physiol 2001; 534: 287–95PubMed

169.

Ferrier KE, Waddell TK, Gatzka CD, et al. Aerobic exercise training does not modify large-artery compliance in isolated systolic hypertension. Hypertension 2001; 38: 222–6PubMed

170.

Snell PG, Martin WH, Buckey JC, et al. Maximal vascular leg conductance in trained and untrained men. J Appl Physiol 1987; 62: 606–10PubMed

171.

Lavrencic A, Salobir BG, Keber I. Physical training improves flow-mediated dilation in patients with the polymetabolic syndrome. Arterioscler Thromb Vasc Biol 2000; 20: 551–5PubMed

172.

Higashi Y, Sasaki S, Kurisu S, et al. Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide. Circulation 1999; 100: 1194–202PubMed

173.

Hambrecht R, Hilbrich L, Erbs S, et al. Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation. J Am Coll Cardiol 2000; 35: 706–13PubMed

174.

Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 2000; 342: 454–60PubMed

175.

Maiorana A, O’Driscoll G, Dembo L, et al. Effect of aerobic and resistance exercise training on vascular function in heart failure. Am J Physiol Heart Circ Physiol 2000; 279: H1999–2005PubMed

176.

Gielen S, Erbs S, Linke A, et al. Home-based versus hospital-based exercise programs in patients with coronary artery disease: effects on coronary vasomotion. Am Heart J 2003; 145: E3PubMed

177.

Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76–9PubMed

178.

Neel JV. The ‘thrifty genotype’ in 1998. Nutr Rev 1999; 57: S2–9PubMed

Title: The Role of Exercise in the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes Mellitus
Authors: Jonathan M. McGavock
Neil D. Eves
Sandra Mandic
Nicole M. Glenn
H. Arthur Quinney
Mark J. Haykowsky
Publication date: 01-01-2004
Publisher: Springer International Publishing
Published in: Sports Medicine / Issue 1/2004
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI: https://doi.org/10.2165/00007256-200434010-00004

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

The Role of Exercise in the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes Mellitus

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2004

Heat Illness in Athletes

Impact Injuries in Baseball

How Many Steps/Day Are Enough?

Neuromuscular Function After Exercise-Induced Muscle Damage